Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1219758

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1219758

North America Bioprocess Validation Market Size, Share & Industry Trends Analysis Report By Stage, By Mode, By Testing Type, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 83 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The North America Bioprocess Validation Market would witness market growth of 7.2% CAGR during the forecast period (2022-2028).

A process validation is the analysis of data gathered throughout the manufacturing and design of a product to confirm that the process can reliably output products of preset standards. Various regulatory authorities have published guidelines relating to process validation. Process validation ensures that different inputs lead to high-quality and consistent outputs.

Process validation is an ongoing procedure that must be frequently adapted as manufacturing feedback is attained. End-to-end validation processes are necessary for determining product quality because the finished-product inspection cannot always determine it. Process validation can be classified into three steps: process design, process qualification, and continued process verification.

The federal government of Canada provided $126 million to the National Research Council of Canada to build a now-completed Biologics Manufacturing center in Montreal. The government of Canada also partnered with the University of Saskatchewan's vaccine and infectious Disease Organization, providing them with a fund of $105.2 million to aid their vaccine and biomanufacturing capacity. With these investments, the government is rebuilding the Canadian ecosystem. That is why, the budget for 2021 doubled the progress made and provided $2.2 billion for implementing the Biomanufacturing and Life Science Strategy.

The US market dominated the North America Bioprocess Validation Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $165.7 Million by 2028. The Canada market is poised to grow at a CAGR of 9.6% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 8.7% during (2022 - 2028).

Based on Stage, the market is segmented into Continued Process Verification, Process Qualification, and Process Design. Based on Mode, the market is segmented into In House and Outsourced. Based on Testing Type, the market is segmented into Bioprocess Residuals Testing, Extractables & Leachables Testing, Viral Clearance Testing, Filtration & Fermentation Systems Testing, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Eurofins Scientific SE, Sartorius AG, Merck KGaA, Lonza Group AG, Danaher Corporation, Charles River Laboratories International, Inc., SGS S.A., Labcorp Corporation, and Cobetter Filtration equipment Co., Ltd.

Scope of the Study

Market Segments covered in the Report:

By Stage

  • Continued Process Verification
  • Process Qualification
  • Process Design

By Mode

  • In House
  • Outsourced

By Testing Type

  • Bioprocess Residuals Testing
  • Extractables & Leachables Testing
  • Viral Clearance Testing
  • Filtration & Fermentation Systems Testing
  • Others

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • Thermo Fisher Scientific, Inc.
  • Eurofins Scientific SE
  • Sartorius AG
  • Merck KGaA
  • Lonza Group AG
  • Danaher Corporation
  • Charles River Laboratories International, Inc.
  • SGS S.A.
  • Labcorp Corporation
  • Cobetter Filtration equipment Co., Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Bioprocess Validation Market, by Stage
    • 1.4.2 North America Bioprocess Validation Market, by Mode
    • 1.4.3 North America Bioprocess Validation Market, by Testing Type
    • 1.4.4 North America Bioprocess Validation Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Bioprocess Validation Market

Chapter 4. North America Bioprocess Validation Market by Stage

  • 4.1 North America Continued Process Verification Market by Country
  • 4.2 North America Process Qualification Market by Country
  • 4.3 North America Process Design Market by Country

Chapter 5. North America Bioprocess Validation Market by Mode

  • 5.1 North America In House Market by Country
  • 5.2 North America Outsourced Market by Country

Chapter 6. North America Bioprocess Validation Market by Testing Type

  • 6.1 North America Bioprocess Residuals Testing Market by Country
  • 6.2 North America Extractables & Leachables Testing Market by Country
  • 6.3 North America Viral Clearance Testing Market by Country
  • 6.4 North America Filtration & Fermentation Systems Testing Market by Country
  • 6.5 North America Others Market by Country

Chapter 7. North America Bioprocess Validation Market by Country

  • 7.1 US Bioprocess Validation Market
    • 7.1.1 US Bioprocess Validation Market by Stage
    • 7.1.2 US Bioprocess Validation Market by Mode
    • 7.1.3 US Bioprocess Validation Market by Testing Type
  • 7.2 Canada Bioprocess Validation Market
    • 7.2.1 Canada Bioprocess Validation Market by Stage
    • 7.2.2 Canada Bioprocess Validation Market by Mode
    • 7.2.3 Canada Bioprocess Validation Market by Testing Type
  • 7.3 Mexico Bioprocess Validation Market
    • 7.3.1 Mexico Bioprocess Validation Market by Stage
    • 7.3.2 Mexico Bioprocess Validation Market by Mode
    • 7.3.3 Mexico Bioprocess Validation Market by Testing Type
  • 7.4 Rest of North America Bioprocess Validation Market
    • 7.4.1 Rest of North America Bioprocess Validation Market by Stage
    • 7.4.2 Rest of North America Bioprocess Validation Market by Mode
    • 7.4.3 Rest of North America Bioprocess Validation Market by Testing Type

Chapter 8. Company Profiles

  • 8.1 Thermo Fisher Scientific, Inc.
    • 8.1.1 Company Overview
    • 8.1.2 Financial Analysis
    • 8.1.3 Segmental and Regional Analysis
    • 8.1.4 Research & Development Expense
    • 8.1.5 Recent strategies and developments:
      • 8.1.5.1 Geographical Expansions:
    • 8.1.6 SWOT Analysis
  • 8.2 Eurofins Scientific SE
    • 8.2.1 Company Overview
    • 8.2.2 Financial Analysis
    • 8.2.3 Regional Analysis
    • 8.2.4 Recent strategies and developments:
      • 8.2.4.1 Partnerships, Collaborations, and Agreements:
      • 8.2.4.2 Acquisition and Mergers:
  • 8.3 Sartorius AG
    • 8.3.1 Company Overview
    • 8.3.2 Financial Analysis
    • 8.3.3 Segmental and Regional Analysis
    • 8.3.4 Research & Development Expenses
    • 8.3.5 Recent strategies and developments:
      • 8.3.5.1 Partnerships, Collaborations, and Agreements:
      • 8.3.5.2 Acquisition and Mergers:
  • 8.4 Merck KGaA
    • 8.4.1 Company Overview
    • 8.4.2 Financial Analysis
    • 8.4.3 Segmental and Regional Analysis
    • 8.4.4 Research & Development Expense
    • 8.4.5 Recent strategies and developments:
      • 8.4.5.1 Partnerships, Collaborations, and Agreements:
      • 8.4.5.2 Product Launches and Product Expansions:
  • 8.5 Lonza Group AG
    • 8.5.1 Company Overview
    • 8.5.2 Financial Analysis
    • 8.5.3 Segmental and Regional Analysis
    • 8.5.4 Research & Development Expenses
    • 8.5.5 Recent strategies and developments:
      • 8.5.5.1 Partnerships, Collaborations, and Agreements:
  • 8.6 Danaher Corporation
    • 8.6.1 Company Overview
    • 8.6.2 Financial Analysis
    • 8.6.3 Segmental and Regional Analysis
    • 8.6.4 Research & Development Expense
  • 8.7 Charles River Laboratories International, Inc.
    • 8.7.1 Company Overview
    • 8.7.2 Financial Analysis
    • 8.7.3 Segmental and Regional Analysis
  • 8.8 SGS S.A.
    • 8.8.1 Company Overview
    • 8.8.2 Financial Analysis
    • 8.8.3 Segmental and Regional Analysis
  • 8.9 Labcorp Corporation
    • 8.9.1 Company Overview
    • 8.9.2 Financial Analysis
    • 8.9.3 Segmental and Regional Analysis
  • 8.10. Cobetter Filtration equipment Co., Ltd.
    • 8.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 North America Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 2 North America Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 3 North America Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 4 North America Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 5 North America Continued Process Verification Market by Country, 2018 - 2021, USD Million
  • TABLE 6 North America Continued Process Verification Market by Country, 2022 - 2028, USD Million
  • TABLE 7 North America Process Qualification Market by Country, 2018 - 2021, USD Million
  • TABLE 8 North America Process Qualification Market by Country, 2022 - 2028, USD Million
  • TABLE 9 North America Process Design Market by Country, 2018 - 2021, USD Million
  • TABLE 10 North America Process Design Market by Country, 2022 - 2028, USD Million
  • TABLE 11 North America Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 12 North America Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 13 North America In House Market by Country, 2018 - 2021, USD Million
  • TABLE 14 North America In House Market by Country, 2022 - 2028, USD Million
  • TABLE 15 North America Outsourced Market by Country, 2018 - 2021, USD Million
  • TABLE 16 North America Outsourced Market by Country, 2022 - 2028, USD Million
  • TABLE 17 North America Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 18 North America Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 19 North America Bioprocess Residuals Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 20 North America Bioprocess Residuals Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 21 North America Extractables & Leachables Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 22 North America Extractables & Leachables Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 23 North America Viral Clearance Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 24 North America Viral Clearance Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 25 North America Filtration & Fermentation Systems Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 26 North America Filtration & Fermentation Systems Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 27 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Bioprocess Validation Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Bioprocess Validation Market by Country, 2022 - 2028, USD Million
  • TABLE 31 US Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 32 US Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 33 US Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 34 US Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 35 US Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 36 US Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 37 US Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 38 US Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 39 Canada Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 40 Canada Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 41 Canada Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 42 Canada Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 43 Canada Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 44 Canada Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 45 Canada Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 46 Canada Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 47 Mexico Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 48 Mexico Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 49 Mexico Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 50 Mexico Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 51 Mexico Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 52 Mexico Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 53 Mexico Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 54 Mexico Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 55 Rest of North America Bioprocess Validation Market, 2018 - 2021, USD Million
  • TABLE 56 Rest of North America Bioprocess Validation Market, 2022 - 2028, USD Million
  • TABLE 57 Rest of North America Bioprocess Validation Market by Stage, 2018 - 2021, USD Million
  • TABLE 58 Rest of North America Bioprocess Validation Market by Stage, 2022 - 2028, USD Million
  • TABLE 59 Rest of North America Bioprocess Validation Market by Mode, 2018 - 2021, USD Million
  • TABLE 60 Rest of North America Bioprocess Validation Market by Mode, 2022 - 2028, USD Million
  • TABLE 61 Rest of North America Bioprocess Validation Market by Testing Type, 2018 - 2021, USD Million
  • TABLE 62 Rest of North America Bioprocess Validation Market by Testing Type, 2022 - 2028, USD Million
  • TABLE 63 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 64 Key Information - Eurofins Scientific SE
  • TABLE 65 KEY INFORMATION - Sartorius AG
  • TABLE 66 key Information - Merck KGaA
  • TABLE 67 Key Information - Lonza Group AG
  • TABLE 68 Key Information - Danaher Corporation
  • TABLE 69 key information - Charles River Laboratories International, Inc.
  • TABLE 70 Key Information - SGS S.A.
  • TABLE 71 Key Information - Labcorp corporation
  • TABLE 72 Key Information - Cobetter filtration equipment co., ltd.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Swot analysis: thermo fisher scientific, inc.
  • FIG 3 Recent strategies and developments: Sartorius AG
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!